CHINA PHARMA HOLDINGS, INC. Revenue Breakdown
No Revenue Breakdown for CPHI on this site yet.
- 2025-12-31: Others Not split by product in the filing$4.14M100.00%; Total revenue $4.14M.
- 2024-12-31: Others Not split by product in the filing$4.53M100.00%; Total revenue $4.53M.
- 2023-12-31: Others Not split by product in the filing$7.01M100.00%; Total revenue $7.01M.
- 2022-12-31: Others Not split by product in the filing$8.10M100.00%; Total revenue $8.10M.
Source checked: the stored Revenue Breakdown page for CPHI.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $4.14M 100.00% | $4.14M |
| 2024-12-31 | Not split by product in the filing $4.53M 100.00% | $4.53M |
| 2023-12-31 | Not split by product in the filing $7.01M 100.00% | $7.01M |
| 2022-12-31 | Not split by product in the filing $8.10M 100.00% | $8.10M |
| 2021-12-31 | Not split by product in the filing $9.64M 100.00% | $9.64M |
| 2020-12-31 | Not split by product in the filing $10.87M 100.00% | $10.87M |
| 2019-12-31 | Not split by product in the filing $10.92M 100.00% | $10.92M |
| 2018-12-31 | Not split by product in the filing $12.33M 100.00% | $12.33M |
| 2017-12-31 | Not split by product in the filing $13.21M 100.00% | $13.21M |
| 2016-12-31 | Not split by product in the filing $15.57M 100.00% | $15.57M |
| 2015-12-31 | Not split by product in the filing $20.35M 100.00% | $20.35M |
| 2014-12-31 | Not split by product in the filing $22.13M 100.00% | $22.13M |
| 2013-12-31 | Not split by product in the filing $32.81M 100.00% | $32.81M |
| 2012-12-31 | Not split by product in the filing $54.51M 100.00% | $54.51M |
| 2011-12-31 | Not split by product in the filing $81.17M 100.00% | $81.17M |
| 2010-12-31 | Not split by product in the filing $74.39M 100.00% | $74.39M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $948.34K 100.00% | $948.34K |
| 2026-03-31 | Not split by product $983.54K 100.00% | $983.54K |
| 2025-12-31 | Not split by product $1.23M 100.00% | $1.23M |
| 2025-09-30 | Not split by product $756.22K 100.00% | $756.22K |
| 2025-06-30 | Not split by product $1.03M 100.00% | $1.03M |
| 2025-03-31 | Not split by product $1.14M 100.00% | $1.14M |
| 2024-12-31 | Not split by product $1.13M 100.00% | $1.13M |
| 2024-09-30 | Not split by product $1.10M 100.00% | $1.10M |
| 2024-06-30 | Not split by product $924.94K 100.00% | $924.94K |
| 2024-03-31 | Not split by product $1.37M 100.00% | $1.37M |
| 2023-12-31 | Not split by product $2.15M 100.00% | $2.15M |
| 2023-09-30 | Not split by product $1.80M 100.00% | $1.80M |
| 2023-06-30 | Not split by product $1.10M 100.00% | $1.10M |
| 2023-03-31 | Not split by product $1.96M 100.00% | $1.96M |
| 2022-12-31 | Not split by product $2.92M 100.00% | $2.92M |
| 2022-09-30 | Not split by product $1.97M 100.00% | $1.97M |
| 2022-06-30 | Not split by product $1.61M 100.00% | $1.61M |
| 2022-03-31 | Not split by product $1.60M 100.00% | $1.60M |
| 2021-12-31 | Not split by product $2.89M 100.00% | $2.89M |
| 2021-09-30 | Not split by product $1.98M 100.00% | $1.98M |
| 2021-06-30 | Not split by product $2.42M 100.00% | $2.42M |
| 2021-03-31 | Not split by product $2.36M 100.00% | $2.36M |
| 2020-12-31 | Not split by product $2.93M 100.00% | $2.93M |
| 2020-09-30 | Not split by product $2.40M 100.00% | $2.40M |
| 2020-06-30 | Not split by product $3.77M 100.00% | $3.77M |
| 2020-03-31 | Not split by product $1.76M 100.00% | $1.76M |
| 2019-12-31 | Not split by product $3.05M 100.00% | $3.05M |
| 2019-09-30 | Not split by product $2.38M 100.00% | $2.38M |
| 2019-06-30 | Not split by product $2.57M 100.00% | $2.57M |
| 2019-03-31 | Not split by product $2.93M 100.00% | $2.93M |
| 2018-12-31 | Not split by product $3.24M 100.00% | $3.24M |
| 2018-09-30 | Not split by product $2.30M 100.00% | $2.30M |
| 2018-06-30 | Not split by product $3.17M 100.00% | $3.17M |
| 2018-03-31 | Not split by product $3.62M 100.00% | $3.62M |
| 2017-12-31 | Not split by product $3.85M 100.00% | $3.85M |
| 2017-09-30 | Not split by product $3.16M 100.00% | $3.16M |
| 2017-06-30 | Not split by product $2.92M 100.00% | $2.92M |
| 2017-03-31 | Not split by product $3.29M 100.00% | $3.29M |
| 2016-12-31 | Not split by product $5.26M 100.00% | $5.26M |
| 2016-09-30 | Not split by product $3.13M 100.00% | $3.13M |
| 2016-06-30 | Not split by product $3.54M 100.00% | $3.54M |
| 2016-03-31 | Not split by product $3.64M 100.00% | $3.64M |
| 2015-12-31 | Not split by product $4.50M 100.00% | $4.50M |
| 2015-09-30 | Not split by product $4.48M 100.00% | $4.48M |
| 2015-06-30 | Not split by product $5.67M 100.00% | $5.67M |
| 2015-03-31 | Not split by product $5.69M 100.00% | $5.69M |
| 2014-12-31 | Not split by product $3.33M 100.00% | $3.33M |
| 2014-09-30 | Not split by product $5.57M 100.00% | $5.57M |
| 2014-06-30 | Not split by product $6.13M 100.00% | $6.13M |
| 2014-03-31 | Not split by product $7.11M 100.00% | $7.11M |
| 2013-12-31 | Not split by product $8.41M 100.00% | $8.41M |
| 2013-09-30 | Not split by product $8.12M 100.00% | $8.12M |
| 2013-06-30 | Not split by product $8.03M 100.00% | $8.03M |
| 2013-03-31 | Not split by product $8.25M 100.00% | $8.25M |
| 2012-12-31 | Not split by product $11.65M 100.00% | $11.65M |
| 2012-09-30 | Not split by product $12.18M 100.00% | $12.18M |
| 2012-06-30 | Not split by product $14.60M 100.00% | $14.60M |
| 2012-03-31 | Not split by product $16.09M 100.00% | $16.09M |
| 2011-12-31 | Not split by product $22.46M 100.00% | $22.46M |
| 2011-09-30 | Not split by product $20.99M 100.00% | $20.99M |
| 2011-06-30 | Not split by product $19.60M 100.00% | $19.60M |
| 2011-03-31 | Not split by product $18.12M 100.00% | $18.12M |
| 2010-12-31 | Not split by product $23.97M 100.00% | $23.97M |
| 2010-09-30 | Not split by product $18.68M 100.00% | $18.68M |
| 2010-06-30 | Not split by product $16.63M 100.00% | $16.63M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |